None
Conditions
Interventions
Sponsors
Soiken Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy subjects aged from 35 to 65 years old 2) Subjects whose systolic blood pressure is 130 mmHg or more and less than 160 mmHg or diastolic blood pressure is 85 mmHg or more and less than 100 mmHg 3) Subjects whose serum LDL cholesterol is 120 mg/dL or more and less than 160 mg/dL 4) Subjects who have a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent
Exclusion criteria
Exclusion criteria: 1) Subjects who have severe liver, cardiovascular, respiratory, endocrine or metabolic diseases 2) Subjects who have the possibility of developing allergic symptoms by the test food 3) Subjects who are during pregnancy or lactation, and intend to be pregnant during the study period 4) Subjects having blood sample of 200 mL or more taken within 1 month, or 400 mL or more within 3 months (e.g. donated blood) prior to the start of the present study 5) Subjects who have a smoking habit 6) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is taking part in another clinical study 7) Subjects determined to be inappropriate by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Forearm blood flow determined by plethysmography | — |
Secondary
| Measure | Time frame |
|---|---|
| Deviation value of vascular aging, vascular age, Waveform index I, Waveform index II determined by accelerated plethysmography, systolic blood pressure, diastolic blood pressure and LDL cholesterol | — |
Countries
Japan
Contacts
Public ContactTomohiro Sugino
Soiken Inc. Representative Director
Outcome results
None listed